1. Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders

   • Francesca Marini
   • Francesca Giusti
   • Maria Luisa Brandi

   Review 18 August 2022 Pages: 213 - 238

   

2. Pharmacist interventions in osteoporosis management: a systematic review

   • Catherine Laird
   • Helen Benson
   • Kylie A. Williams

   Review Open access 14 October 2022 Pages: 239 - 254

   

3. Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis

   • Safoora Poorirani
   • Sayed latif Taheri
   • Sayed Abolfazl Mostafavi

   Review 15 October 2022 Pages: 255 - 267

   

4. Comparison of various treatment modalities for the management of bone marrow edema syndrome/transient osteoporosis in men and non-pregnant women: a systematic review

   • Konstantinos Paraskevopoulos
   • Anthimos Keskinis
   • Athanasios N. Ververidis

   Review 12 November 2022 Pages: 269 - 290

   

5. Discontinuation of denosumab in men with prostate cancer

   • Anne Sophie Sølling
   • Torben Harsløf
   • Bente Langdahl

   Original Article 19 November 2022 Pages: 291 - 297

   

6. An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures

   • Benjamin Tze Keong Ding
   • Hai Fon Lim
   • Remesh Kunnasegaran

   Original Article 21 November 2022 Pages: 299 - 307

   

7. Lipopolysaccharide-binding protein and bone health: data from a population-based sample of men

   • Jasmine R. Cleminson
   • Julie A. Pasco
   • Lana J. Williams

   Original Article 21 November 2022 Pages: 309 - 317

8. Comparison of DXA-based versus CT-based indices to predict prevalent fracture history in men with spinal cord injury

   • Michael J. Matthews
   • Karen L. Troy
   • Leslie R. Morse

   Original Article 23 November 2022 Pages: 319 - 325

   

9. A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients

   • Elisabeth Ng
   • Claudia Ashkar
   • Shoshana Sztal-Mazer

   Original Article 24 November 2022 Pages: 327 - 337

   

10. Fracture liaison service model: project design and accreditation

    • U. Tarantino
    • C. Greggi
    • M. L. Brandi

    Original Article Open access 24 November 2022 Pages: 339 - 348

    

11. Mortality following proximal humerus fracture—a nationwide register study of 147,692 fracture patients in Sweden

    • Bakir O. Sumrein
    • Hans E. Berg
    • Tuomas T. Huttunen

    Original Article Open access 26 November 2022 Pages: 349 - 356

    

12. Variation in bone mineral density and fractures over 20 years among Canadians: a comparison of the Canadian Multicenter Osteoporosis Study and the Canadian Longitudinal Study on Aging

    • Nazila Hassanabadi
    • Claudie Berger
    • Suzanne N. Morin

    Original Article Open access 30 November 2022 Pages: 357 - 367

    

13. Retrospective analyses of clinical features in 28 Chinese patients with type V osteogenesis imperfecta: new perspectives in an old issue

    • Zhijia Tan
    • Hiu Tung Shek
    • Michael Kai Tsun To

    Original Article Open access 02 December 2022 Pages: 369 - 377

    

14. Trends in anti-osteoporotic medication utilization following fragility fracture in the USA from 2011 to 2019

    • Amil R. Agarwal
    • Jordan S. Cohen
    • Gregory J. Golladay

    Original Article 03 December 2022 Pages: 379 - 385

    

15. Association of bisphosphonates with diabetes risk and glycemic control: a meta-analysis

    • Po-Wei Chen
    • Hsiao-Yuan Su
    • Shu-Man Lin

    Original Article 05 December 2022 Pages: 387 - 397

    

16. Frailty and risk of subsequent fracture among older adults presenting to hospital with a minimal trauma fracture

    • Ha Mai
    • Lynette Mc Evoy
    • Steven A. Frost

    Original Article 06 December 2022 Pages: 399 - 404

    

17. Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis

    • Pilar Peris
    • Ana Monegal
    • Eva González-Roca

    Short Communication 18 November 2022 Pages: 405 - 411

    

18. Comments on “Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up”

    • C. Li
    • K. Lu

    Letter to the Editor 21 November 2022 Pages: 413 - 414

19. Author response to the comments on our article Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up

    • Ilona Nurmi-Lüthje
    • Raine Tiihonen
    • Peter Lüthje

    Letter to the Editor 21 November 2022 Pages: 415 - 416

20. Estimation of osteoporosis prevalence among a population is reasonable only after the concerned reference bone mineral density database and cutpoint T-score have been validated

    • Yì Xiáng J. Wáng

    Letter to the Editor 29 November 2022 Pages: 417 - 418

21. Response to: Estimation of osteoporosis prevalence among a population is reasonable only after the concerned reference bone mineral density database and cutpoint T-score have been validated

    • Pei-Lun Xiao
    • Hua-Ding Lu

    Letter to the Editor 29 November 2022 Pages: 419 - 420

22. Appropriate dosing of burosumab in tumor-induced osteomalacia

    • Luciano Colangelo
    • Chiara Sonato
    • Salvatore Minisola

    Letter to the Editor 01 December 2022 Pages: 421 - 421

23. Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia

    • C. Crotti
    • F. Zucchi
    • M. Varenna

    Letter to the Editor 01 December 2022 Pages: 423 - 424

24. Sarcopenia, osteoporosis, and fractures: what we see mainly depends on how we look?

    • M. Kara
    • L. Özçakar

    Letter to the Editor 05 December 2022 Pages: 425 - 426

25. Response letter to “sarcopenia, osteoporosis and fractures: what we see”

    • Rebekah J. Harris
    • Neeta Parimi
    • Jane A. Cauley

    Letter to the Editor 05 December 2022 Pages: 427 - 427